A Zika virus (ZIKV) outbreak has been ongoing in central and south America for the past 2 years, and has raised global concerns with regards to public health. ZIKV has been shown to infect neural progenitor cells (NPCs) and inhibits cell proliferation, growth of neurospheres and brain organoids, suggesting that the neuropathology induced by ZIKV might be associated with NPC cell fate. However, ...
From June 2015, unprecedented epidemics of Zika virus (ZIKV) occur in the Americas, which cause the unexpected clinical symptoms including Guillain-Barre？ syndrome, microcephaly and other birth defects in human. To date, there is no effective licensed vaccine or antiviral treatment against ZIKV infection, although several vaccine candidates have been described including formalin inactivated va...
Junin virus (JUNV) is the pathogen of Argentine haemorrhagic fever which results in high lethality, while there is limited therapeutics available. In a recent study from research group led by Prof. XIAO Gengfu in Wuhan Institute of Virology of the Chinese Academy of Sciences, a series of mAbs were isolated based on a newly established strategy, and five were proven to effectively neutralize JUN...
Lassa virus (LASV) is an enveloped, negative-sense, bi-segmented RNA virus belonging to the Mammarenavirus genus (family Arenaviridae). To date, no vaccines or specific antiviral agents against LASV are available. Therapy strategies are limited to the administration of ribavirin in the early course of the illness.
